United States Biotechnology & Medical Research

Dynavax Technologies Corp (DVAX)

Track

Ticker: DVAX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Dynavax Technologies Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 15 Jan 2026
Value US$3,398,936.49 | Price 122.27 | Shares 56,199 (-10.4%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-20 2026-01-15 PlS Planned sale
3.3
Novack David F

President & COO

Officer
56,199 -10.4%
122.27
US$3,398,936 		56,199 -10.4% 122.27 US$3,398,936
2026-01-15 2026-01-15 PrS Proposed sale
3.3
DAVID NOVACK

Officer

Officer
95,902
389.31
US$697,640 		95,902 389.31 US$697,640
2025-12-29 2025-12-24 PrS Proposed sale
3.3
DAVID NOVACK

Officer

Officer
40,291
496.72
US$2,532,222 		40,291 496.72 US$2,532,222
2025-12-29 2025-12-24 PlS Planned sale
3.3
Novack David F

President & COO

Officer
30,000 -21.2%
15.49
US$464,700 		30,000 -21.2% 15.49 US$464,700
2025-08-25 2025-08-22 B Purchase
1.7
Myers Scott Dunseth
Non-Executive Director
3,800 +12.2%
10.82
US$41,116 		3,800 +12.2% 10.82 US$41,116
2025-08-22 2025-08-22 S Sale
2.3
Deep Track Biotechnology Master Fund, Ltd.
Large shareholder
970,143 -5.8%
10.59
US$10,273,814 		970,143 -5.8% 10.59 US$10,273,814
2025-08-22 2025-08-21 S Sale
2.3
Deep Track Biotechnology Master Fund, Ltd.
Large shareholder
1,094,994 -6.2%
11.03
US$12,077,784 		1,094,994 -6.2% 11.03 US$12,077,784
2025-03-26 2025-03-24 PlS Planned sale
3.3
Novack David F

President & COO

Officer
10,000 -55.3%
14.00
US$140,000 		10,000 -55.3% 14.00 US$140,000
2025-03-24 2025-03-24 PrS Proposed sale
3.3
DAVID NOVACK

Officer

Officer
10,000
14.00
US$140,000 		10,000 14.00 US$140,000
2025-03-20 2025-03-18 PlS Planned sale
3.3
Novack David F

President & COO

Officer
14,020 -63.4%
13.58
US$190,392 		14,020 -63.4% 13.58 US$190,392
2025-03-18 2025-03-18 PrS Proposed sale
3.3
DAVID NOVACK

Officer

Officer
14,020
13.58
US$190,386 		14,020 13.58 US$190,386
2025-03-10 2025-03-07 PlS Planned sale
3.3
Novack David F

President & COO

Officer
32,764 -59.7%
14.39
US$471,474 		32,764 -59.7% 14.39 US$471,474
2025-03-07 2025-03-07 PrS Proposed sale
3.3
DAVID NOVACK

Officer

Officer
32,764
14.39
US$471,376 		32,764 14.39 US$471,376
2024-06-03 2024-05-31 S Sale
3.8
CANO FRANCIS
Non-Executive Director
3,615 -8.9%
11.93
US$43,127 		3,615 -8.9% 11.93 US$43,127
2024-03-04 2024-03-01 S Sale
3.4
Burgess Justin

Chief Accounting Officer

Officer
13,425 -100.0%
12.78
US$171,572 		13,425 -100.0% 12.78 US$171,572
2024-03-04 2024-03-01 S Sale
3.4
Burgess Justin

Chief Accounting Officer

Officer
7,101 -34.6%
12.78
US$90,751 		7,101 -34.6% 12.78 US$90,751
2024-03-01 2024-03-01 PrS Proposed sale
3.4
Burgess Justin

Officer

Officer
20,526
12.78
US$262,353 		20,526 12.78 US$262,353
2024-01-08 2024-01-04 PlS Planned sale
3.6
Janssen Robert

SVP and CMO

Officer
1,500 -2.9%
15.00
US$22,500 		1,500 -2.9% 15.00 US$22,500
2024-01-04 2024-01-04 PrS Proposed sale
3.6
Janssen Robert

Officer

Officer
82,144
15.72
US$1,291,486 		82,144 15.72 US$1,291,486
2024-01-04 2024-01-02 PlS Planned sale
3.3
Novack David F

President & COO

Officer
9,000 -73.8%
14.45
US$130,050 		9,000 -73.8% 14.45 US$130,050
2024-01-02 2024-01-02 PrS Proposed sale
3.3
DAVID NOVACK

Officer

Officer
9,000
14.45
US$130,025 		9,000 14.45 US$130,025
2023-12-05 2023-12-01 PlS Planned sale
3.3
Novack David F

President & COO

Officer
20,000 -86.3%
13.56
US$271,200 		20,000 -86.3% 13.56 US$271,200
2023-12-01 2023-12-01 PrS Proposed sale
3.3
DAVID NOVACK

Officer

Officer
20,000
13.56
US$271,119 		20,000 13.56 US$271,119
2023-11-17 2023-11-17 PrS Proposed sale
3.3
Andrew A. F. Hack

Former Director

Non-Executive Director
81,250
13.53
US$1,099,313 		81,250 13.53 US$1,099,313
2023-11-07 2023-11-03 PlS Planned sale
3.3
Novack David F

President & COO

Officer
20,000 -86.3%
15.00
US$300,000 		20,000 -86.3% 15.00 US$300,000
2023-11-03 2023-11-03 PrS Proposed sale
3.3
DAVID NOVACK

Officer

Officer
20,000
15.00
US$300,000 		20,000 15.00 US$300,000
2023-11-03 2023-11-01 PlS Planned sale
3.3
Novack David F

President & COO

Officer
20,000 -86.3%
14.12
US$282,400 		20,000 -86.3% 14.12 US$282,400
2023-11-01 2023-11-01 PrS Proposed sale
3.3
DAVID NOVACK

Officer

Officer
20,000
14.12
US$282,392 		20,000 14.12 US$282,392
2023-10-24 2023-10-24 PrS Proposed sale
BAIN CAPITAL LIFE SCIENCES FUND, LP

Former Affiliate
376,887
13.81
US$5,204,809 		376,887 13.81 US$5,204,809
2023-10-24 2023-10-24 PrS Proposed sale
BCIP LIFE SCIENCES ASSOCIATES, LP

Former Affiliate
38,113
13.81
US$526,341 		38,113 13.81 US$526,341
2023-10-11 2023-10-10 PlS Planned sale
3.6
Janssen Robert

SVP and CMO

Officer
1,755 -3.4%
15.01
US$26,343 		1,755 -3.4% 15.01 US$26,343
2023-10-10 2023-10-10 PrS Proposed sale
BAIN CAPITAL LIFE SCIENCES FUND, LP

Former Affiliate
453,572
14.73
US$6,681,116 		453,572 14.73 US$6,681,116
2023-10-10 2023-10-10 PrS Proposed sale
BCIP LIFE SCIENCES ASSOCIATES, LP

Former Affiliate
46,428
14.73
US$683,884 		46,428 14.73 US$683,884
2023-10-04 2023-10-02 PlS Planned sale
3.3
Novack David F

President & COO

Officer
20,000 -86.3%
15.00
US$300,000 		20,000 -86.3% 15.00 US$300,000
2023-10-04 2023-10-02 PlS Planned sale
3.3
Novack David F

President & COO

Officer
20,000 -46.3%
14.75
US$295,000 		20,000 -46.3% 14.75 US$295,000
2023-10-03 2023-10-02 PlS Planned sale
3.6
Janssen Robert

SVP and CMO

Officer
5,015 -9.1%
15.03
US$75,375 		5,015 -9.1% 15.03 US$75,375
2023-10-02 2023-10-02 PrS Proposed sale
3.3
DAVID NOVACK

Officer

Officer
40,000
14.87
US$594,971 		40,000 14.87 US$594,971
2023-09-05 2023-09-01 PlS Planned sale
3.3
Novack David F

President & COO

Officer
20,000 -86.3%
14.48
US$289,600 		20,000 -86.3% 14.48 US$289,600
2023-09-01 2023-09-01 PrS Proposed sale
3.3
DAVID NOVACK

Officer

Officer
20,000
14.48
US$289,612 		20,000 14.48 US$289,612
2023-08-29 2023-08-29 PrS Proposed sale
3.8
CANO FRANCIS

Director

Non-Executive Director
25,000
14.85
US$371,250 		25,000 14.85 US$371,250
2023-08-25 2023-08-24 PlS Planned sale
3.6
Janssen Robert

SVP and CMO

Officer
600 -1.2%
15.02
US$9,012 		600 -1.2% 15.02 US$9,012
2023-08-24 2023-08-23 PlS Planned sale
3.6
Janssen Robert

SVP and CMO

Officer
34,857 -41.1%
15.01
US$523,204 		34,857 -41.1% 15.01 US$523,204
2023-08-10 2023-08-08 PlS Planned sale
3.3
Novack David F

President & COO

Officer
20,000 -86.3%
15.01
US$300,200 		20,000 -86.3% 15.01 US$300,200
2023-08-10 2023-08-08 PlS Planned sale
3.3
Novack David F

President & COO

Officer
10,000 -30.1%
14.73
US$147,300 		10,000 -30.1% 14.73 US$147,300
2023-08-10 2023-08-08 PlS Planned sale
3.3
Novack David F

President & COO

Officer
10,000 -23.2%
14.74
US$147,400 		10,000 -23.2% 14.74 US$147,400
2023-08-10 2023-08-08 S Sale
3.3
Hack Andrew A. F.
Non-Executive Director
1,500,000 -62.1%
14.39
US$21,585,000 		1,500,000 -62.1% 14.39 US$21,585,000
2023-08-09 2023-08-08 PlS Planned sale
3.6
Janssen Robert

SVP and CMO

Officer
2,600 -5.0%
15.05
US$39,130 		2,600 -5.0% 15.05 US$39,130
2023-08-08 2023-08-08 PrS Proposed sale
3.3
DAVID NOVACK

Officer

Officer
40,000
14.87
US$594,824 		40,000 14.87 US$594,824
2023-08-08 2023-08-08 PrS Proposed sale
3.6
Janssen Robert

Officer

Officer
113,250
14.89
US$1,686,292 		113,250 14.89 US$1,686,292
2023-08-08 2023-08-08 PrS Proposed sale
BAIN CAPITAL LIFE SCIENCES FUND, LP

Affiliate
1,360,717
14.75
US$20,070,575 		1,360,717 14.75 US$20,070,575
2023-08-08 2023-08-08 PrS Proposed sale
BCIP LIFE SCIENCES ASSOCIATES, LP

Affiliate
139,283
14.75
US$2,054,424 		139,283 14.75 US$2,054,424
2023-08-08 2023-08-07 S Sale
3.4
Burgess Justin

Chief Accounting Officer

Officer
8,061 -100.0%
14.55
US$117,247 		8,061 -100.0% 14.55 US$117,247
2023-08-07 2023-08-07 PrS Proposed sale
3.4
Burgess Justin

Officer

Officer
8,061
14.54
US$117,244 		8,061 14.54 US$117,244
2023-06-16 2023-06-14 S Sale
3.3
Hack Andrew A. F.
Non-Executive Director
500,000 -17.2%
12.68
US$6,340,000 		500,000 -17.2% 12.68 US$6,340,000
2023-06-14 2023-06-14 PrS Proposed sale
BAIN CAPITAL LIFE SCIENCES FUND, LP

Affiliate
453,572
12.56
US$5,696,864 		453,572 12.56 US$5,696,864
2023-06-14 2023-06-14 PrS Proposed sale
BCIP LIFE SCIENCES ASSOCIATES, LP

Affiliate
46,428
12.56
US$583,136 		46,428 12.56 US$583,136
2023-05-19 2023-05-18 S Sale
3.3
Hack Andrew A. F.
Non-Executive Director
1,000,000 -25.5%
10.55
US$10,550,000 		1,000,000 -25.5% 10.55 US$10,550,000
2023-05-18 2023-05-18 PrS Proposed sale
BAIN CAPITAL LIFE SCIENCES FUND, LP

Affiliate
907,145
11.13
US$10,096,523 		907,145 11.13 US$10,096,523
2023-05-18 2023-05-18 PrS Proposed sale
BCIP LIFE SCIENCES ASSOCIATES, LP

Affiliate
92,855
11.13
US$1,033,476 		92,855 11.13 US$1,033,476
2023-05-05 2023-05-04 S Sale
3.3
Novack David F

President & COO

Officer
17,515 -84.6%
10.90
US$190,914 		17,515 -84.6% 10.90 US$190,914
2023-05-04 2023-05-04 PrS Proposed sale
3.3
Novack David F

Officer

Officer
17,515
10.50
US$183,908 		17,515 10.50 US$183,908
2023-03-01 2023-02-27 S Sale
3.4
Burgess Justin

Chief Accounting Officer

Officer
4,121 -100.0%
10.32
US$42,529 		4,121 -100.0% 10.32 US$42,529
2023-03-01 2023-02-27 S Sale
3.4
Burgess Justin

Chief Accounting Officer

Officer
5,400 -56.7%
10.39
US$56,106 		5,400 -56.7% 10.39 US$56,106
2023-03-01 2023-02-27 S Sale
3.4
Burgess Justin

Chief Accounting Officer

Officer
3,017 -24.1%
10.39
US$31,347 		3,017 -24.1% 10.39 US$31,347
2023-03-01 2023-02-27 S Sale
3.4
Burgess Justin

Chief Accounting Officer

Officer
3,950 -48.9%
10.39
US$41,040 		3,950 -48.9% 10.39 US$41,040
2023-03-01 2023-02-27 S Sale
3.4
Burgess Justin

Chief Accounting Officer

Officer
2,717 -25.2%
10.39
US$28,230 		2,717 -25.2% 10.39 US$28,230
2023-03-01 2023-02-27 S Sale
3.4
Burgess Justin

Chief Accounting Officer

Officer
1,872 -31.2%
10.39
US$19,450 		1,872 -31.2% 10.39 US$19,450
2023-03-01 2023-02-27 S Sale
3.4
Burgess Justin

Chief Accounting Officer

Officer
1,294 -17.8%
10.39
US$13,445 		1,294 -17.8% 10.39 US$13,445
2022-12-08 2022-12-06 S Sale
3.3
Hack Andrew A. F.
Non-Executive Director
1,500,000 -27.7%
11.60
US$17,400,000 		1,500,000 -27.7% 11.60 US$17,400,000
2022-11-10 2022-11-08 S Sale
3.3
Novack David F

President & COO

Officer
52,204 -96.2%
12.47
US$650,984 		52,204 -96.2% 12.47 US$650,984
2022-08-17 2022-08-15 S Sale
3.3
Hack Andrew A. F.
Non-Executive Director
3,000,000 -35.7%
14.68
US$44,040,000 		3,000,000 -35.7% 14.68 US$44,040,000
2022-08-10 2022-08-09 S Sale
3.3
Novack David F

President & COO

Officer
26,250 -33.0%
16.92
US$444,037 		26,250 -33.0% 16.92 US$444,037
2022-08-10 2022-08-09 S Sale
1.8
Spencer Ryan

CEO and Director

Executive Director
14,921 -9.4%
16.92
US$252,399 		14,921 -9.4% 16.92 US$252,399
2022-08-10 2022-08-09 S Sale
3.6
Janssen Robert

Senior Vice President

Officer
7,938 -18.3%
16.92
US$134,277 		7,938 -18.3% 16.92 US$134,277
2022-08-10 2022-08-08 S Sale
3.8
CANO FRANCIS
Non-Executive Director
15,000 -41.9%
17.17
US$257,550 		15,000 -41.9% 17.17 US$257,550
Explore more

More insider trading research around Dynavax Technologies Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America